Tyra Biosciences director more sells $250k in shares
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tyra Biosciences Inc (TYRA)
Assess today's live Tyra Biosciences Inc (TYRA) share price, performance and insights using our live NASDAQ: TYRA stock exchange data.
Analyse the historical data and Tyra Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Tyra Biosciences share price buy/sell indicators using real-time data (or discuss the Tyra Biosciences (TYRA) stock price today with other investors in the Tyra Biosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TYRA share price (ISIN: US90240B1061) to enhance your trading decisions with our free investment tools and resources.
What Is the Tyra Biosciences Inc Share Price Today?
The Tyra Biosciences share price today is 25.83.
What Is the Stock Symbol for Tyra Biosciences Inc
The stock symbol (or 'ticker') for Tyra Biosciences Inc is "TYRA."
What Stock Exchange Does Tyra Biosciences Inc Trade On?
Tyra Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Tyra Biosciences Inc a Good Stock to Buy?
Determining whether Tyra Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Tyra Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Tyra Biosciences share price buy/sell indicators using real-time data (or discuss the Tyra Biosciences (TYRA) stock price today with other investors in the Tyra Biosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TYRA share price (ISIN: US90240B1061) to enhance your trading decisions with our free investment tools and resources.
What Is the Tyra Biosciences Inc Share Price Today?
The Tyra Biosciences share price today is 25.83.
What Is the Stock Symbol for Tyra Biosciences Inc
The stock symbol (or 'ticker') for Tyra Biosciences Inc is "TYRA."
What Stock Exchange Does Tyra Biosciences Inc Trade On?
Tyra Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Tyra Biosciences Inc a Good Stock to Buy?
Determining whether Tyra Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.65
26.03
52 wk Range
6.42
26.09
TYRA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.6526.03
52 wk Range
6.4226.09
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TYRA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
33.00
Upside
+27.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Tyra Biosciences Company Profile
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Compare TYRA to Peers and Sector
Metrics to compare | TYRA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTYRAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.3x | −6.7x | −0.6x | |
PEG Ratio | 0.64 | −0.16 | 0.00 | |
Price/Book | 4.9x | 2.6x | 2.6x | |
Price / LTM Sales | - | 19.2x | 3.2x | |
Upside (Analyst Target) | 27.8% | 79.7% | 41.8% | |
Fair Value Upside | Unlock | −3.5% | 5.1% | Unlock |
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 33.00
(+27.76% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-0.50 / -0.50
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Tyra Biosciences (TYRA) Share Price Today?
The live Tyra Biosciences share price today is 25.83
What Stock Exchange Does Tyra Biosciences (TYRA) Trade On?
Tyra Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Tyra Biosciences?
The stock symbol (also called a 'ticker') for Tyra Biosciences is "TYRA."
What Is the Current Tyra Biosciences Market Cap?
As of today, Tyra Biosciences market capitalisation is 1.35B.
What Is Tyra Biosciences's (TYRA) Earnings Per Share (TTM)?
The Tyra Biosciences EPS is currently -1.88 (Trailing Twelve Months).
When Is the Next Tyra Biosciences Earnings Date?
Tyra Biosciences's next earnings report will be released on 25 Mar 2026.
Is TYRA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Tyra Biosciences moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Tyra Biosciences Stock Split?
Tyra Biosciences has split 0 times. (See the TYRA stock split history page for full effective split date and price information.)
How Many Employees Does Tyra Biosciences Have?
Tyra Biosciences has 60 employees.
What is the current trading status of Tyra Biosciences (TYRA)?
As of 24 Dec 2025, Tyra Biosciences (TYRA) is trading at a price of 25.83, with a previous close of 25.38. The stock has fluctuated within a day range of 24.65 to 26.03, while its 52-week range spans from 6.42 to 26.09.
What Is Tyra Biosciences (TYRA) Price Target According to Analysts?
The average 12-month price target for Tyra Biosciences is USD33, with a high estimate of USD37 and a low estimate of USD28. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +27.76% Upside potential.
What Is the TYRA After Hours Price?
TYRA's last after hours stock price is 26.70, the stock has decreased by 0.87, or 3.37%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.